최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기American journal of kidney diseases : the official journal of the National Kidney Foundation, v.36 no.6, 2000년, pp.1193 - 1200
Kramer, L. , Gendo, A. , Madl, C. , Ferrara, I. , Funk, G. , Schenk, P. , Sunder-Plassmann, G. , Horl, W.H.
Extracorporeal detoxification has been proposed to treat patients with hepatic encephalopathy (HE) not responding to standard therapy. To investigate the biocompatibility of a cuprophane charcoal-based detoxification device, a prospective, randomized, controlled study was performed. Of 41 consecutiv...
Eur J Clin Invest Ferenci 22 573 1992 10.1111/j.1365-2362.1992.tb01508.x Current concepts in the pathophysiology of hepatic encephalopathy
Ferenci 443 1999 Hepatic encephalopathy: Treatment
Neurochem Pathol Butterworth 6 1 1987 10.1007/BF02833598 Ammonia: A key factor in the pathogenesis of hepatic encephalopathy
Gastroenterology Basile 108 818 1995 10.1016/0016-5085(95)90456-5 The relationship between plasma and brain quinolinic acid levels and the severity of hepatic encephalopathy
Semin Liver Dis Mullen 16 255 1996 10.1055/s-2007-1007238 Natural benzodiazepines and hepatic encephalopathy
Semin Liver Dis Hughes 16 435 1996 10.1055/s-2007-1007256 Use of bioartificial and artificial liver support devices
Gastroenterology O’Grady 94 1186 1988 10.1016/0016-5085(88)90011-X Controlled trials of charcoal hemoperfusion and prognostic factors in fulminant hepatic failure
Eur J Clin Invest Weston 7 401 1977 10.1111/j.1365-2362.1977.tb01626.x Biocompatibility of coated and uncoated charcoal during haemoperfusion in healthy dogs
Int J Artif Organs Ash 15 151 1992 Clinical effects of a sorbent suspension dialysis system in treatment of hepatic coma (the BioLogic-DT)
ASAIO J Ash 38 382 1992 Neurologic improvement of patients with hepatic failure and coma during sorbent suspension dialysis
Int J Artif Organs Hughes 17 657 1994 10.1177/039139889401701207 Evaluation of the BioLogic-DT sorbent-suspension dialyzer in patients with fulminant hepatic failure
Int J Artif Organs Ellis 22 27 1999 10.1177/039139889902200107 Temporary extracorporeal liver support for severe acute alcoholic hepatitis using the Biologic-DT
Semin Liver Dis Rolando 16 389 1996 10.1055/s-2007-1007252 Bacterial and fungal infection in acute liver failure
Liver Transpl Surg Hughes 1 200 1995 10.1002/lt.500010312 Evaluation of extracorporeal bioartificial liver devices
Am J Kidney Dis Hakim 32 suppl 4 S71 1998 10.1016/S0272-6386(98)70165-9 Influence of the dialysis membrane on outcome of ESRD patients
Kidney Int Hörl 28 791 1985 10.1038/ki.1985.199 Plasma levels of granulocyte elastase during hemodialysis: Effects of different dialyzer membranes
Artif Organs Gawaz 23 29 1999 10.1046/j.1525-1594.1999.06289.x Platelet-leukocyte aggregates during hemodialysis: Effect of membrane type
N Engl J Med Arnaout 312 457 1985 10.1056/NEJM198502213120801 Increased expression of an adhesion-promoting surface glycoprotein in the granulocytopenia of hemodialysis
J Am Soc Nephrol Böhler 7 234 1996 10.1681/ASN.V72234 Reduction of granulocyte activation during hemodialysis with regional citrate anticoagulation: Dissociation of complement activation and neutropenia from neutrophil degranulation
Am J Kidney Dis Canivet 21 41 1994 10.1016/S0272-6386(12)80810-9 Cuprophane but not synthetic membrane induces increases in serum tumor necrosis factor-alpha levels during hemodialysis
Am J Kidney Dis Girndt 35 95 2000 10.1016/S0272-6386(00)70307-6 Prospective crossover trial of the influence of vitamin E-coated dialyzer membranes on T-cell activation and cytokine induction
N Engl J Med Hakim 331 1338 1994 10.1056/NEJM199411173312003 Effect of the dialysis membrane in the treatment of patients with acute renal failure
J Am Soc Nephrol Himmelfarb 9 257 1998 10.1681/ASN.V92257 A multicenter comparison of dialysis membranes in the treatment of acute renal failure requiring dialysis
Lancet Schiffl 344 570 1994 10.1016/S0140-6736(94)91964-X Biocompatible membranes in acute renal failure: Prospective case-controlled study
Lancet Jörres 354 1337 1999 10.1016/S0140-6736(99)01213-1 Haemodialysis-membrane biocompatibility and mortality of patients with dialysis-dependent acute renal failure: A prospective randomised multicentre trial
Haemostasis Paramo 25 305 1995 Increased concentrations of tumor necrosis factor and interleukin-6 contribute to the hemostatic abnormalities in advanced liver disease
Am J Gastroenterol Genesca 94 169 1999 10.1111/j.1572-0241.1999.00790.x Interleukin-6, nitric oxide, and the clinical and hemodynamic alterations of patients with liver cirrhosis
N Engl J Med Levi 341 586 1999 10.1056/NEJM199908193410807 Disseminated intravascular coagulation
Int J Artif Organs Ellis 22 27 1999 10.1177/039139889902200107 Temporary extracorporeal liver support for severe acute alcoholic hepatitis using the BioLogic-DT
J Hepatol Bakker 15 330 1992 10.1016/0168-8278(92)90064-V Disseminated intravascular coagulation in liver cirrhosis
Scand J Gastroenterol Prytz 11 857 1976 10.1080/00365521.1976.12097199 Portal venous and systemic endotoxaemia in patients without liver disease and systemic endotoxaemia in patients with cirrhosis
Gastroenterology Violi 109 531 1995 10.1016/0016-5085(95)90342-9 Association between low-grade disseminated intravascular coagulation and endotoxemia in patients with liver cirrhosis
Am Surg Cohen 56 665 1990 The inactivation of antithrombin III by serum elastase in patients with surgical infections
Cancer Gabazza 72 2134 1993 10.1002/1097-0142(19931001)72:7<2134::AID-CNCR2820720712>3.0.CO;2-8 Correlation between increased granulocyte elastase release and activation of blood coagulation in patients with lung cancer
Am J Gastroenterol Ben-Ari 94 2977 1999 10.1111/j.1572-0241.1999.01446.x Disseminated intravascular coagulation in liver cirrhosis: Fact or fiction?
Circulation Pernerstorfer 100 2485 1999 10.1161/01.CIR.100.25.2485 Heparin blunts endotoxin-induced coagulation activation
Blood Pernerstorfer 95 1729 2000 10.1182/blood.V95.5.1729.005k16_1729_1734 Lepirudin blunts endotoxin-induced coagulation activation
Wien Klin Wochenschr Apsner 109 123 1997 Impairment of citrate metabolism in acute hepatic failure
Hepatology Kramer 28 410A 1998 A controlled study of the BioLogic-DT system in chronic hepatic encephalopathy
Clin Nephrol Hörl 25 304 1986 Different complement and granulocyte activation in patients dialyzed with PMMA dialysers
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.